🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this trial is to investigate the effect of multiple doses of fli...
Status
Completed
Location
511.158.1 Boehringer Ingelheim Investigational Site
Start Date
2010-06
Trial ID
NCT01134965
Treatments Being Tested
This is a double-blinded, placebo-controlled randomized phase II clinical t...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-07-02
Trial ID
NCT04743934
Treatments Being Tested
To determine if long-term treatment with Flibanserin is safe and to monitor...
Status
Terminated
Location
511.84.01079 Boehringer Ingelheim Investigational Site
Start Date
2007-02
Trial ID
NCT00441558
Treatments Being Tested
This trial examines the way flibanserin is metabolized in postmenopausal wo...
Status
Completed
Location
511.146.01003 Boehringer Ingelheim Investigational Site
Start Date
2010-07
Trial ID
NCT01188603
Treatments Being Tested
This trial is designed to assess the safety and efficacy of flibanserin in ...
Status
Completed
Location
511.70.01068 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00360243
Treatments Being Tested
The purpose of this study is to determine if the study drug will increase s...
Status
Terminated
Location
Baylor College of Medicine
Start Date
2020-05-08
Trial ID
NCT04002661
Treatments Being Tested
An open label randomized, single dose, two-way crossover bioequivalence stu...
Status
Completed
Location
Genuine Research Center GRC
Start Date
2018-12-12
Trial ID
NCT04494191
Treatments Being Tested
To estimate the duration of efficacy with continued treatment of double-bli...
Status
Completed
Location
511.74.01051 Boehringer Ingelheim Investigational Site
Start Date
2006-01
Trial ID
NCT00277914
Treatments Being Tested
This trial is designed to assess the safety and efficacy of flibanserin in ...
Status
Completed
Location
511.75.01015 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00360555
Treatments Being Tested
Safety profile of flibanserin over 28 additional weeks Distribution of pref...
Status
Completed
Location
511.118.43005 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00601367
Treatments Being Tested